Saroja Pharma Industries India (NSE:SAROJA) COGS-to-Revenue : 0.88 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Saroja Pharma Industries India COGS-to-Revenue?

Saroja Pharma Industries India's Cost of Goods Sold for the six months ended in Mar. 2024 was ₹356.4 Mil. Its Revenue for the six months ended in Mar. 2024 was ₹406.7 Mil.

Saroja Pharma Industries India's COGS to Revenue for the six months ended in Mar. 2024 was 0.88.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Saroja Pharma Industries India's Gross Margin % for the six months ended in Mar. 2024 was 12.36%.

Saroja Pharma Industries India COGS-to-Revenue Historical Data

The historical data trend for Saroja Pharma Industries India's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Saroja Pharma Industries India COGS-to-Revenue Chart

Saroja Pharma Industries India Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

0.91

0.90

0.88

Saroja Pharma Industries India Semi-Annual Data
	Mar21	Mar22	Mar23	Mar24
COGS-to-Revenue	0.91	0.90	0.90	0.88

Saroja Pharma Industries India COGS-to-Revenue Calculation

Saroja Pharma Industries India's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	356.409	/	406.693
	=	0.88

Saroja Pharma Industries India's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	356.409	/	406.693
	=	0.88

Saroja Pharma Industries India (NSE:SAROJA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Saroja Pharma Industries India's Gross Margin % for the six months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	356.409 / 406.693
	=	12.36 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Saroja Pharma Industries India COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Saroja Pharma Industries India's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Saroja Pharma Industries India Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Saroja Pharma Industries India Ltd (NSE:SAROJA) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080

Website

https://www.sarojapharma.com

Saroja Pharma Industries India Ltd is a company engaged in pharmaceutical and healthcare sector. The Company trades in Pharma Active Pharmaceutical Ingredients, Pharma Intermediates, Chemicals, Solvents used for pharmaceutical products human and veterinary medicines. The Company has only one reportable Business Segment which is Pharma Chemicals like Thionyl Chloride and Pharmaceuticals intermeddles etc.

Saroja Pharma Industries India Headlines

No Headlines